Anixa Biosciences Ownership
| ANIX Stock | USD 3.15 0.01 0.32% |
Anixa |
Anixa Stock Ownership Analysis
About 18.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.4. Anixa Biosciences had not issued any dividends in recent years. The entity had 1:25 split on the 26th of June 2015. Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California. Anixa Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Anixa Biosciences please contact Amit Kumar at 408 708 9808 or go to https://www.anixa.com.Anixa Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Anixa Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Anixa Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Anixa Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Anixa Biosciences Outstanding Bonds
Anixa Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Anixa Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Anixa bonds can be classified according to their maturity, which is the date when Anixa Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ANHEUSER BUSCH INC Corp BondUS035229CQ41 | View | |
| US035229DA89 Corp BondUS035229DA89 | View | |
| US035229CG68 Corp BondUS035229CG68 | View | |
| ABIBB 68 20 AUG 32 Corp BondUS035229CJ08 | View | |
| ANHEUSER BUSCH INC Corp BondUS035229DC46 | View | |
| US03523TAP30 Corp BondUS03523TAP30 | View | |
| ANHEUSER BUSCH INBEV Corp BondUS03523TBW71 | View | |
| ANHEUSER BUSCH INBEV Corp BondUS03523TBV98 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Anixa Stock Analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.